GLP-1 treatment linked to lower risk of hospitalization and death in older adults with fatty liver disease

A study found that older adults with fatty liver disease who received GLP-1-based treatment had significantly lower risks of liver disease-related complications, hospitalization, and death. This could improve treatment options for fatty liver disease.